PRECEE2 Perinatal Research (PRECEE2)
April 10, 2025 updated by: Centre Hospitalier Universitaire de Besancon
Research Into Perinatal Care, Its Complications and Exposure to Multiple Factors (PRECEE2)
The aim of this study is to analyze the relationship between complications and adverse pregnancy outcomes and exposure to environmental factors in women living in Franche-Comté who gave birth between 2011 and 2025 at Besancon University Hospital.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
30000
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Women who gave birth at the CHUB between 01/01/2011 and 12/31/2025
Description
Inclusion Criteria:
- Women who gave birth at the CHUB between 01/01/2011 and 12/31/2025
- who have not expressed any objection to the processing of their data.
Exclusion Criteria:
- Legal incapacity or limited legal capacity
- Subject is within the exclusion period of another study or is excluded from the "national volunteer file".
- Subject refusing the collection of his/her medical data.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pregnancy complications
Time Frame: at birth
|
Description of Pregnancy Complications
|
at birth
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 10, 2025
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
January 31, 2026
Study Registration Dates
First Submitted
March 27, 2025
First Submitted That Met QC Criteria
April 10, 2025
First Posted (Actual)
April 18, 2025
Study Record Updates
Last Update Posted (Actual)
April 18, 2025
Last Update Submitted That Met QC Criteria
April 10, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022/688
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.